These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7845548)

  • 1. Effects of acute and chronic treatment with amoxapine and cericlamine on the sleep-wakefulness cycle in the rat.
    Maudhuit C; Jolas T; Lainey E; Hamon M; Adrien J
    Neuropharmacology; 1994 Aug; 33(8):1017-25. PubMed ID: 7845548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Implications of 5-HT2 receptors in the increase of slow wave sleep in healthy volunteers under amoxapine].
    Loas G
    Encephale; 1991 Dec; 17 Spec No 3():423-5. PubMed ID: 1807968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central action of 5-HT3 receptor ligands in the regulation of sleep-wakefulness and raphe neuronal activity in the rat.
    Adrien J; Tissier MH; Lanfumey L; Haj-Dahmane S; Jolas T; Franc B; Hamon M
    Neuropharmacology; 1992 Jun; 31(6):519-29. PubMed ID: 1407392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-dependent effect of ketanserin on the sleep-waking phases in rats.
    Kirov R; Moyanova S
    Int J Neurosci; 1998 Apr; 93(3-4):257-64. PubMed ID: 9639243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats.
    Bjorvatn B; Ursin R
    Behav Brain Res; 1990 Nov; 40(3):239-46. PubMed ID: 2149499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the 5-HT2 antagonist ritanserin on sleep-walking cycle in the rat.
    Silhol S; Glin L; Gottesmann C
    Pharmacol Biochem Behav; 1992 Jan; 41(1):241-3. PubMed ID: 1539075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related effect of ritanserin on the sleep-waking phases in rats.
    Kirov R; Moyanova S
    Int J Neurosci; 1998 Apr; 93(3-4):265-78. PubMed ID: 9639244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectra.
    Kantor S; Jakus R; Molnar E; Gyongyosi N; Toth A; Detari L; Bagdy G
    J Pharmacol Exp Ther; 2005 Nov; 315(2):921-30. PubMed ID: 16085759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preclinical pharmacology of amoxapine and amitriptyline. Implications of serotoninergic and opiodergic systems in their central effect in rats].
    Gozlan H; Saddiki-Traki F; Merahi N; Laguzzi R; Hamon M
    Encephale; 1991 Dec; 17 Spec No 3():415-22. PubMed ID: 1666997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The light-dark cycle modulates the effects of ritanserin on sleep-wakefulness patterns in the rat.
    Dugovic C; Leysen JE; Janssen PF; Wauquier A
    Pharmacol Biochem Behav; 1989 Nov; 34(3):533-7. PubMed ID: 2516324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat.
    Ponzoni A; Monti JM; Jantos H
    Eur J Pharmacol; 1993 Nov; 249(3):259-64. PubMed ID: 8287912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities.
    Saletu B; Frey R; Krupka M; Anderer P; Grünberger J; See WR
    Sleep; 1991 Oct; 14(5):439-47. PubMed ID: 1836894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of serotonergic projection from dorsal raphe nucleus to basolateral amygdala on sleep-waking cycle of rats.
    Gao J; Zhang JX; Xu TL
    Brain Res; 2002 Jul; 945(1):60-70. PubMed ID: 12113952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ritanserin-induced changes in sleep-waking phases in rats.
    Kirov R; Moyanova S
    Acta Physiol Pharmacol Bulg; 1995; 21(4):87-92. PubMed ID: 8830880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of ozone exposure on the sleep-wake cycle and serotonin contents in the pons of the rat.
    Paz C; Huitron-Resendiz S
    Neurosci Lett; 1996 Feb; 204(1-2):49-52. PubMed ID: 8929975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505.
    Kantor S; Jakus R; Balogh B; Benko A; Bagdy G
    Br J Pharmacol; 2004 Aug; 142(8):1332-42. PubMed ID: 15265808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the selective 5-hydroxytryptamine uptake inhibitors paroxetine and zimeldine on EEG sleep and waking stages in the rat.
    Kleinlogel H; Burki HR
    Neuropsychobiology; 1987; 17(4):206-12. PubMed ID: 2964564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT1-like receptor agonists enhance wakefulness.
    Dzoljic MR; Ukponmwan OE; Saxena PR
    Neuropharmacology; 1992 Jul; 31(7):623-33. PubMed ID: 1407402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
    Monti JM; Jantos H
    Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.